Cargando…
Effectiveness of dual antiplatelet de-escalation therapy on the prognosis of patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention
AIM: To investigate the effectiveness of de-escalation of ticagrelor (from ticagrelor 90 mg to clopidogrel 75 mg or ticagrelor 60 mg) on the prognosis of patients with ST segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI) after 3 months of oral dual a...
Autores principales: | Zhao, Zhigang, Wang, Jingyao, Lei, Mengjie, Li, Yachao, Yang, Yanli, An, Lei, Sun, Xue, Li, Cairong, Xue, Zengming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061818/ https://www.ncbi.nlm.nih.gov/pubmed/36991321 http://dx.doi.org/10.1186/s12872-023-03152-8 |
Ejemplares similares
-
A novel de-escalation antiplatelet therapy for patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Li, Yachao, et al.
Publicado: (2023) -
Effect of pretreatment with a P2Y(12) inhibitor in patients with non-ST-elevation acute coronary syndrome: a systematic review and network meta-analysis
por: Li, Yachao, et al.
Publicado: (2023) -
Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction
por: Gao, Lei, et al.
Publicado: (2014) -
Risks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic Review
por: Nascimento, Bruno Ramos, et al.
Publicado: (2014) -
Hyperuricemia is Associated With 2- and 5-Year Adverse Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Tang, Xiao-Fang, et al.
Publicado: (2022)